Compare Stocks

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CEMI Chembio Diagnostics	$0.46	$0.43	$0.19 ▼ $1.24	$16.71M	1.85	661,416 shs	351,642 shs
PLXP PLx Pharma		$0.00	$0.02 ▼ $0.04	$603K	3.79	12.96 million shs	3,000 shs
RMTI Rockwell Medical	$1.48	$1.49	$1.16 ▼ $6.24	$43.45M	1.17	220,034 shs	220,842 shs
VBLT Vascular Biogenics	$5.46 -8.8%	$0.40	$0.10 ▼ $6.74	$423.91M	0.77	2.19 million shs	161,505 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CEMI Chembio Diagnostics	0.00%	0.00%	0.00%	0.00%	+1.11%
PLXP PLx Pharma	0.00%	0.00%	0.00%	0.00%	-99.29%
RMTI Rockwell Medical	0.00%	-8.64%	+4.96%	+7.25%	-29.86%
VBLT Vascular Biogenics	0.00%	0.00%	0.00%	0.00%	+2,547.91%

You’re invited: Biggest crypto event of 2024 (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CEMI Chembio Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PLXP PLx Pharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RMTI Rockwell Medical	3.8362 of 5 stars	3.5	3.0	0.0	4.1	3.3	0.0	0.6
VBLT Vascular Biogenics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CEMI Chembio Diagnostics	N/A	N/A	N/A	N/A
PLXP PLx Pharma	N/A	N/A	N/A	N/A
RMTI Rockwell Medical	3.00	Buy	$7.00	372.97% Upside
VBLT Vascular Biogenics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest PLXP, RMTI, VBLT, and CEMI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/25/2024	RMTI Rockwell Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$11.00 ➝ $9.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CEMI Chembio Diagnostics	$48.34M	0.35	N/A	N/A	$0.48 per share	0.95
PLXP PLx Pharma	$4.54M	0.00	N/A	N/A	$1.30 per share	0.00
RMTI Rockwell Medical	$83.61M	0.52	$0.02 per share	76.76	$0.75 per share	1.97
VBLT Vascular Biogenics	$660K	642.29	N/A	N/A	$0.32 per share	17.06

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CEMI Chembio Diagnostics	-$23.29M	-$1.20	N/A	∞	N/A	-47.03%	-113.57%	-38.22%	N/A
PLXP PLx Pharma	-$46.13M	-$1.85	N/A	N/A	N/A	-606.91%	-291.11%	-119.43%	N/A
RMTI Rockwell Medical	-$8.44M	-$0.40	N/A	24.67	N/A	-10.09%	-39.17%	-13.87%	5/14/2024 (Confirmed)
VBLT Vascular Biogenics	-$32.30M	-$0.21	N/A	∞	N/A	N/A	-73.45%	-54.11%	N/A

Latest PLXP, RMTI, VBLT, and CEMI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/14/2024	N/A	RMTI Rockwell Medical	-$0.05	N/A	+$0.05	N/A	N/A	N/A
3/21/2024	Q4 2023	RMTI Rockwell Medical	-$0.08	$0.02	+$0.10	$0.09	$22.09 million	$22.09 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CEMI Chembio Diagnostics	N/A	N/A	N/A	N/A	N/A
PLXP PLx Pharma	N/A	N/A	N/A	N/A	N/A
RMTI Rockwell Medical	N/A	N/A	N/A	N/A	N/A
VBLT Vascular Biogenics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CEMI Chembio Diagnostics	N/A	1.23	1.04
PLXP PLx Pharma	N/A	4.79	4.28
RMTI Rockwell Medical	0.46	1.73	1.38
VBLT Vascular Biogenics	N/A	4.63	4.63

Ownership

Institutional Ownership

Company	Institutional Ownership
CEMI Chembio Diagnostics	8.65%
PLXP PLx Pharma	21.19%
RMTI Rockwell Medical	23.31%
VBLT Vascular Biogenics	0.96%

Insider Ownership

Company	Insider Ownership
CEMI Chembio Diagnostics	3.30%
PLXP PLx Pharma	8.95%
RMTI Rockwell Medical	2.20%
VBLT Vascular Biogenics	6.13%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CEMI Chembio Diagnostics	337	36.73 million	35.51 million	Not Optionable
PLXP PLx Pharma	16	29.14 million	26.53 million	Not Optionable
RMTI Rockwell Medical	237	29.36 million	28.69 million	Optionable
VBLT Vascular Biogenics	7	77.64 million	72.88 million	Optionable

PLXP, RMTI, VBLT, and CEMI Headlines

Source	Headline
	Tommy Garten elected to VBL Hall of Fame therecorderonline.com - March 28 at 1:31 PM
	Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system nature.com - February 21 at 3:29 PM
	Vascular News and Research news-medical.net - November 25 at 2:28 PM
	Vascular Biogenics (VBLT) Price Target Increased by 160.00% to 13.26 msn.com - November 3 at 12:39 AM
	Notable Labs Closes Merger Transaction With VBL Therapeutics finance.yahoo.com - October 16 at 3:55 PM
	VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting finance.yahoo.com - October 12 at 3:13 PM
	VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting finance.yahoo.com - October 4 at 8:40 AM
	Vascular Biogenics Rises on Presentation Hype finance.yahoo.com - September 9 at 12:00 PM
	VBLT Stock Sees Decline of Approximately -0.22% in Last Five Days knoxdaily.com - September 7 at 9:15 PM
	VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC finance.yahoo.com - September 6 at 7:30 PM
	VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT businesswire.com - August 28 at 7:00 PM
	VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT businesswire.com - August 28 at 3:04 PM
	VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - August 14 at 8:09 AM
	Monitoring Vascular Biogenics Ltd. (VBLT) after recent insider movements knoxdaily.com - July 26 at 4:10 PM
	Vascular Biogenics (NASDAQ: VBLT) fool.com - July 23 at 5:52 PM
	Recent Insider Activity Suggests Potential Gains for Vascular Biogenics Ltd. (VBLT) knoxdaily.com - July 12 at 4:20 PM
	VBLT Stock Sees Decline of Approximately -4.31% in Last Five Days knoxdaily.com - July 7 at 2:11 PM
	Days-to-cover ratio for VBLT surges to 0.84 due to rise in short interest knoxdaily.com - June 23 at 8:26 PM
	The Role of Peripheral Arterial Disease in the Pathogenesis of Diabetic Foot Disease: When to Refer for Vascular Surgery medscape.com - May 18 at 1:35 AM
	VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - May 15 at 8:03 PM
	Developing a Patient-Centered Approach to Vascular Access Device Selection medscape.com - May 10 at 8:52 AM
	CADASIL: The Most Common Hereditary Subcortical Vascular Dementia medscape.com - May 5 at 1:05 AM
	Aspirin in Stroke Prevention in Nonvalvular Atrial Fibrillation and Stable Vascular Disease medscape.com - May 2 at 8:00 PM
	Vascular Biogenics Stock (NASDAQ:VBLT), Dividends benzinga.com - April 4 at 1:52 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Chembio Diagnostics

NASDAQ:CEMI

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.

PLx Pharma

NASDAQ:PLXP

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.

Rockwell Medical

NASDAQ:RMTI

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Vascular Biogenics

NASDAQ:VBLT

Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial